Cornerstone Planning Group’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.84K | Sell |
11
-17
| -61% | -$2.85K | ﹤0.01% | 969 |
|
|
2025
Q1 | $3.05K | Buy |
28
+15
| +115% | +$1.64K | ﹤0.01% | 877 |
|
|
2024
Q4 | $2.16K | Sell |
13
-11
| -46% | -$1.82K | ﹤0.01% | 780 |
|
|
2024
Q3 | $4.42K | Sell |
24
-4
| -14% | -$736 | ﹤0.01% | 588 |
|
|
2024
Q2 | $6.34K | Sell |
28
-12
| -30% | -$2.72K | ﹤0.01% | 525 |
|
|
2024
Q1 | $9.34K | Sell |
40
-35
| -47% | -$8.17K | ﹤0.01% | 420 |
|
|
2023
Q4 | $17.7K | Buy |
75
+25
| +50% | +$5.91K | 0.01% | 332 |
|
|
2023
Q3 | $9.8K | Sell |
50
-15
| -23% | -$2.94K | ﹤0.01% | 424 |
|
|
2023
Q2 | $13.7K | Buy |
+65
| New | +$13.7K | 0.01% | 541 |
|
|
2022
Q4 | $19.9K | Buy |
+85
| New | +$19.9K | 0.01% | 441 |
|